Official UK procurement notice
Biorepository and Processing services
Authority: GENOMICS ENGLAND LIMITED (Central government)
What is being bought
Published requirement descriptionThe services cover end‑to‑end management of biological samples, including receipt, verification and secure storage in controlled ultra‑low‑temperature environments. Samples are processed through a range of laboratory workflows that include DNA and RNA extraction, quality control testing, normalisation, and preparation for downstream sequencing all delivered on a per‑sample basis, there is no fixed maximum number of samples. Additional activities include aliquoting, pooling, reformatting into required labware, and arranging shipments to designated laboratories. Project‑specific workflows may be developed to meet bespoke requirements.
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 16 Feb 2026, 15:13 GMT
- Last source update
- 2 Oct 2026, 13:29 BST
- Authority reference
GEL-HE-25732- FTS notice number
2026/S 000-093354- Latest notice
- Contract details notice (UK7)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-065523Find a Tender
- Why no open competition
- Additional Repeat Extension Partial Replacement
- Published justification
The delivery of services under a new contract with the existing supplier is proposed in accordance with Schedule 5, Paragraph 7 of the Procurement Act 2023, which enables a direct award where a change of supplier would result in incompatible goods or services and where such incompatibility would give rise to disproportionate technical difficulties in operation or maintenance. The remaining activity represents a continuation of established work already underway within the programme, and the new contractual arrangement does not introduce any additional or materially altered services.
Transitioning to an alternative supplier at this stage would require substantial changes to embedded methodologies, operational processes and systems integration, resulting in significant incompatibilities with the established technical approach. Crucially, a change of supplier would also necessitate the transportation of a substantial volume of biological samples to a new provider. This introduces a material and unacceptable risk of contamination, loss, degradation or compromise of sample integrity, given the heightened handling requirements, increased logistical steps, and the sensitivity of the sample types involved. Such risks would directly threaten the comparability, consistency and scientific validity of programme outputs.
Managing these transportation risks-alongside the need to migrate complex datasets, workflows and sample handling processes-would introduce disproportionate technical difficulties, as anticipated under Schedule 5, Paragraph 7, and would undermine the robustness of the study's established operational and analytical frameworks. Maintaining service delivery with the incumbent supplier therefore ensures continuity of technical methodologies, operational processes and quality controls, safeguarding the reliability and stability of the remaining programme work.
In these circumstances, awarding a new contract to the existing supplier meets the criteria under Schedule 5, Paragraph 7, as a change in supplier would result in incompatible services and introduce unreasonable and disproportionate technical and logistical difficulties. The direct award is therefore the most appropriate, proportionate and compliant procurement route under the Procurement Act 2023.
How it was run
Official notice- Submission deadline
- —
Timeline
4 Mar 2026 → 2 Oct 2026 · 2 dates- Standstill ends226 days ago4 Mar 2026, 23:59 GMT
- Notice published15 days ago2 Oct 2026, 13:29 BST
Notice history
4 events · 3 releases on Find a Tender · since 16 Feb 2026- Transparency notice published16 Feb 2026, 15:13 GMTUK5
- Contract award notice published23 Feb 2026, 10:59 GMTUK6
- Contract signature expected27 Mar 2026, 23:59 GMTscheduled
- Contract details notice published2 Oct 2026, 13:29 BSTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Uk Biocentre Ltd1 Apr 2026 – 31 Mar 2028Options: The contract does not provide an automatic or unilateral right to make additional purchases; however, it does enable further services or increased volumes to be added through its formal Change Control procedure. Under the formal Change Control Procedure, any expansion of scope-such as additional processing, storage capacity, new workflows, or increased sample batching volumes-must be requested, assessed, and mutually agreed by both parties before becoming contractually binding. This mechanism allows the Authority to procure additional work when needed but only through a structured and approved variation to the existing services. | £1,843,498 | 23 Feb 2026 | Awarded |
Contracts
GEL-HE-25372 Biorepository and Processing services · Uk Biocentre Ltd
- Signed
- 30 Sept 2026
- Value
- £1,843,498
- Period
- 30 Sept 2026 – 31 Mar 2028
- Status
- active
- Options
- The contract does not provide an automatic or unilateral right to make additional purchases; however, it does enable further services or increased volumes to be added through its formal Change Control procedure. Under the formal Change Control Procedure, any expansion of scope-such as additional processing, storage capacity, new workflows, or increased sample batching volumes-must be requested, assessed, and mutually agreed by both parties before becoming contractually binding. This mechanism allows the Authority to procure additional work when needed but only through a structured and approved variation to the existing services.
No agreed KPIs: KPIs have been included within the contract, however the contract value does not reach the relevant threshold therefore publication is not necessary.
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- UK BIOCENTRE LIMITEDAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender